NCT02604004View on ClinicalTrials.gov

Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HIV INFECTIONS
Interventions
DRUG

Epivir ® tablet 150-mg single dose (drug reference)

Bioequivalence lamivudine 150 mg tablets fasting condition

DRUG

Lamivudine 150-mg tablet single dose (drug test)

Bioequivalence lamivudine 150 mg tablets fasting condition

All Listed Sponsors
lead

Universidade Federal de Pernambuco

OTHER

NCT02604004 - Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers | Biotech Hunter | Biotech Hunter